James Morgan Cunningham, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ebolavirus | 6 | 2021 | 250 | 1.470 |
Why?
|
| Receptors, Virus | 5 | 2018 | 650 | 1.200 |
Why?
|
| Viral Envelope Proteins | 8 | 2018 | 639 | 1.170 |
Why?
|
| Virus Internalization | 5 | 2018 | 502 | 0.970 |
Why?
|
| Lassa virus | 1 | 2018 | 99 | 0.580 |
Why?
|
| Avian leukosis virus | 2 | 2007 | 18 | 0.530 |
Why?
|
| Hemorrhagic Fever, Ebola | 2 | 2021 | 424 | 0.510 |
Why?
|
| Mutant Proteins | 1 | 2017 | 486 | 0.480 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 1740 | 0.400 |
Why?
|
| Cathepsin B | 2 | 2017 | 80 | 0.380 |
Why?
|
| Epidemics | 1 | 2017 | 514 | 0.360 |
Why?
|
| Cholesterol | 2 | 2018 | 2902 | 0.340 |
Why?
|
| Vero Cells | 3 | 2018 | 481 | 0.340 |
Why?
|
| Avian Proteins | 2 | 2007 | 77 | 0.340 |
Why?
|
| Retroviridae Infections | 1 | 2007 | 148 | 0.290 |
Why?
|
| Gene Products, env | 1 | 2007 | 250 | 0.270 |
Why?
|
| Sulfhydryl Compounds | 1 | 2007 | 296 | 0.260 |
Why?
|
| Membrane Fusion | 2 | 2004 | 264 | 0.240 |
Why?
|
| Cathepsins | 1 | 2005 | 242 | 0.220 |
Why?
|
| Mink Cell Focus-Inducing Viruses | 1 | 2003 | 3 | 0.220 |
Why?
|
| Leukemia Virus, Feline | 1 | 2003 | 4 | 0.210 |
Why?
|
| Endosomes | 2 | 2005 | 521 | 0.210 |
Why?
|
| Cysteine | 1 | 2007 | 897 | 0.210 |
Why?
|
| Cysteine Endopeptidases | 1 | 2005 | 542 | 0.200 |
Why?
|
| Cell Line | 9 | 2021 | 15540 | 0.200 |
Why?
|
| Niacinamide | 1 | 2024 | 419 | 0.200 |
Why?
|
| NAD | 1 | 2024 | 618 | 0.170 |
Why?
|
| Protein Folding | 1 | 2004 | 868 | 0.170 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2020 | 433 | 0.140 |
Why?
|
| Adamantane | 1 | 2018 | 148 | 0.140 |
Why?
|
| Lassa Fever | 1 | 2018 | 97 | 0.140 |
Why?
|
| Metabolome | 1 | 2024 | 1005 | 0.140 |
Why?
|
| Esters | 1 | 2018 | 213 | 0.140 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 390 | 0.140 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2007 | 2476 | 0.140 |
Why?
|
| Protein Stability | 1 | 2018 | 576 | 0.130 |
Why?
|
| Cell Fusion | 2 | 2007 | 294 | 0.120 |
Why?
|
| Membrane Glycoproteins | 2 | 2017 | 3690 | 0.120 |
Why?
|
| Virulence | 1 | 2017 | 1289 | 0.100 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 1331 | 0.100 |
Why?
|
| Antiviral Agents | 2 | 2018 | 3053 | 0.100 |
Why?
|
| Cricetinae | 3 | 2014 | 2412 | 0.100 |
Why?
|
| Models, Molecular | 2 | 2018 | 5377 | 0.100 |
Why?
|
| Carrier Proteins | 2 | 2017 | 4909 | 0.100 |
Why?
|
| Selection, Genetic | 1 | 2017 | 877 | 0.100 |
Why?
|
| Marburgvirus | 1 | 2011 | 19 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2018 | 3749 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 1463 | 0.080 |
Why?
|
| Drug Carriers | 1 | 2014 | 701 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2017 | 2879 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4257 | 0.080 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2011 | 287 | 0.080 |
Why?
|
| Polymers | 1 | 2014 | 1622 | 0.070 |
Why?
|
| Animals | 11 | 2018 | 168735 | 0.070 |
Why?
|
| Transfection | 1 | 2014 | 5738 | 0.070 |
Why?
|
| Virion | 2 | 2005 | 428 | 0.060 |
Why?
|
| Cathepsin L | 1 | 2005 | 69 | 0.060 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2005 | 93 | 0.060 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2005 | 185 | 0.060 |
Why?
|
| Hospitalization | 1 | 2024 | 10810 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2011 | 1798 | 0.060 |
Why?
|
| Leukemia Virus, Murine | 1 | 2003 | 95 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 5691 | 0.050 |
Why?
|
| Nanoparticles | 1 | 2014 | 1966 | 0.050 |
Why?
|
| Exocytosis | 1 | 2003 | 323 | 0.050 |
Why?
|
| Solubility | 1 | 2004 | 1077 | 0.050 |
Why?
|
| Crystallization | 1 | 2003 | 518 | 0.050 |
Why?
|
| Cats | 1 | 2003 | 972 | 0.050 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2003 | 434 | 0.040 |
Why?
|
| Neocortex | 1 | 2004 | 414 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2010 | 2010 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2003 | 23597 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2003 | 2172 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2010 | 3213 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2003 | 1944 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2021 | 674 | 0.040 |
Why?
|
| Cell Membrane | 2 | 2004 | 3635 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2020 | 698 | 0.040 |
Why?
|
| Humans | 13 | 2024 | 765926 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2003 | 1743 | 0.030 |
Why?
|
| Mice | 6 | 2014 | 81782 | 0.030 |
Why?
|
| HIV | 1 | 2003 | 1587 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2004 | 3945 | 0.030 |
Why?
|
| Virus Replication | 1 | 2003 | 2450 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2003 | 2196 | 0.030 |
Why?
|
| Mutation | 2 | 2018 | 30192 | 0.030 |
Why?
|
| Phylogeny | 1 | 2021 | 2837 | 0.030 |
Why?
|
| Androstenes | 1 | 2014 | 177 | 0.030 |
Why?
|
| Cricetulus | 1 | 2014 | 806 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2020 | 1062 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 2021 | 1761 | 0.020 |
Why?
|
| CHO Cells | 1 | 2014 | 1372 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 4394 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 13398 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 1559 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 17596 | 0.020 |
Why?
|
| Endocytosis | 1 | 2014 | 952 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2005 | 18962 | 0.020 |
Why?
|
| Haplorhini | 1 | 2010 | 520 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 3733 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2823 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2010 | 735 | 0.020 |
Why?
|
| Genotype | 1 | 2021 | 13026 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 15878 | 0.020 |
Why?
|
| Neurons | 1 | 2004 | 9527 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2004 | 12129 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2020 | 3637 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2014 | 4161 | 0.010 |
Why?
|
| Paired Box Transcription Factors | 1 | 2004 | 204 | 0.010 |
Why?
|
| Phenotype | 1 | 2021 | 16714 | 0.010 |
Why?
|
| Epitopes | 1 | 2010 | 2523 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 17060 | 0.010 |
Why?
|
| Gene Products, gag | 1 | 2003 | 317 | 0.010 |
Why?
|
| Protein Array Analysis | 1 | 2004 | 398 | 0.010 |
Why?
|
| Biological Products | 1 | 2011 | 947 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2004 | 1748 | 0.010 |
Why?
|
| Eye Proteins | 1 | 2004 | 628 | 0.010 |
Why?
|
| DNA | 1 | 2014 | 7193 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 852 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2004 | 1138 | 0.010 |
Why?
|
| Protein Transport | 1 | 2003 | 1938 | 0.010 |
Why?
|
| Protein Binding | 1 | 2010 | 9296 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 11895 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2004 | 2430 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2004 | 2969 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 3606 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9239 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2004 | 9541 | 0.010 |
Why?
|
| Aged | 1 | 2024 | 171163 | 0.010 |
Why?
|
| Middle Aged | 1 | 2024 | 223016 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 223088 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2004 | 14450 | 0.000 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 9525 | 0.000 |
Why?
|
| Male | 1 | 2024 | 363815 | 0.000 |
Why?
|
| Female | 1 | 2024 | 396141 | 0.000 |
Why?
|